HomeTagsLeronlimab

Leronlimab

Healthcare

Regnum Signs Agreement with CytoDyn and SevenScore Pharma to Commercialize HIV Drug Leronlimab

PR Newswire - January 11, 2022

Regnum Corp., and SevenScore Pharmaceuticals, LLC ("SevenScore"), announced the assignment of the Commercialization and License Agreement ("CLA") and a related Supply Agreement to commercialize...

Biotechnology

Leronlimab (350 mg) Weekly Use for 14 Weeks in Open Label Arm of NASH Trial Produces Fibrosis Reduction as High as 93 msec Amongst...

Business Wire - November 26, 2021

CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, reported data from its trial treating...